BALPHARMA.BOBALPHARMA.BOBSE
Loading
ROE: Returns DecliningContracting
Percentile Rank64
3Y CAGR-0.9%
Studio
Year-over-Year Change

Return on equity

3Y CAGR
-0.9%/yr
vs +22.3%/yr prior
Acceleration
-23.2pp
Decelerating
Percentile
P64
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
20259.32%-12.6%
202410.67%+164.6%
20234.03%-57.9%
20229.57%+8.1%
20218.85%+138.0%
2020-23.31%-510.0%
20195.68%+32.8%
20184.28%+35.8%
20173.15%+23.2%
20162.56%-